![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, November 17, 2023 9:49:47 AM
We saw Dale file his purchase of the Baudax shares, as required. Humanigen did not disclose a merger, but I don't see how we could have, since there is a problem with the accounting for the Tera-Immune acquisition.
The recall of our loaned shares is a stand alone function. I don't see how this issue could undue management's right to recall their loaned shares, if I'm right about that happening.
The impact of the recall could be historic, especially if announced with news of regulatory approval or purchase agreements. There are a number of market participants who will lose market share, or be subjected to heavy losses, if required to buy-in shares. They will use every trick in the book to prevent that, to include attacking the auditing firms. We need to be structured as defensively as possible.
But I think it's important to understand the concerns recently voiced by shareholders such as you, sosjtb, and Preciouslife1. This has been a grueling process for all of us, including management, I'm sure.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM